The platelet-to-lymphocyte ratio as a significant prognostic factor to predict survival outcomes in patients with synchronous metastatic renal cell carcinoma

PURPOSE: The clinical impact of the platelet-to-lymphocyte ratio (PLR) on the prognosis of patients with metastatic renal cell carcinoma (mRCC) remains controversial. We investigated the associations between elevation of the PLR and disease prognosis in patients with synchronous mRCC. MATERIALS AND...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuk, Hyeong Dong, Kang, Minyong, Hwang, Eu Chang, Park, Jae Young, Jeong, Chang Wook, Song, Cheryn, Seo, Seong Il, Byun, Seok-Soo, Kwak, Cheol, Hong, Sung-Hoo, Chung, Jinsoo, Lee, Hakmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Urological Association 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458873/
https://www.ncbi.nlm.nih.gov/pubmed/32734724
http://dx.doi.org/10.4111/icu.20200002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458873/
https://www.ncbi.nlm.nih.gov/pubmed/32734724
http://dx.doi.org/10.4111/icu.20200002

Ejemplares similares